Publications by authors named "Paul England"

Claim this Profile
declarations: a creative new remedy, but what are its limits?
Paul England

Pharm Pat Anal· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surface plasmon resonance biosensor assay for the analysis of small-molecule inhibitor binding to human and parasitic phosphodiesterases.
Marco Siderius, Anitha Shanmugham, Paul England, Tiffany van der Meer, Jan Paul Bebelman

Anal Biochem· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fragment-based screening in tandem with phenotypic screening provides novel antiparasitic hits.
Antoni R Blaazer, Kristina M Orrling, Anitha Shanmugham, Chimed Jansen, Louis Maes, Paul England

J Biomol Screen· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simple colorimetric trypanothione reductase-based assay for high-throughput screening of drugs against Leishmania intracellular amastigotes.
Erika van den Bogaart, Gerard J Schoone, Paul England, Dorien Faber, Kristina M Orrling

Antimicrob Agents Chemother· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preliminary injunctions in generic and branded patent litigation.
Simon Cohen, Paul England

Expert Opin Ther Pat· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Small and colorful stones make beautiful mosaics: fragment-based chemogenomics.
Chris de Graaf, Henry F Vischer, Gerdien E de Kloe, Albert J Kooistra, Saskia Nijmeijer, Paul J England

Drug Discov Today· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Catechol pyrazolinones as trypanocidals: fragment-based design, synthesis, and pharmacological evaluation of nanomolar inhibitors of trypanosomal phosphodiesterase B1.
Kristina M Orrling, Chimed Jansen, Xuan Lan Vu, Vreni Balmer, Patrick Bregy, Paul England

J Med Chem· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reaction to the Brüstle decision.
Scott Parker, Paul England

Pharm Pat Anal· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medicines discovery in the 21st century: the case for a stakeholder corporation.
John Dixon, Paul England, Geoff Lawton, Peter Machin, Alan Palmer

Drug Discov Today· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An interview with Paul England, Ph.D., ProXara Biotechnology, Ltd. Interviewed by Vicki Glaser.
Paul England

Assay Drug Dev Technol· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis